Open-minded to open innovation and precompetitive collaboration

Clinical Pharmacology and Therapeutics

Volumn 87, Issue 5, 2010, Pages 511-515

  Wagner, J A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG; VX 770;

CLINICAL TRIAL; CYSTIC FIBROSIS; DECISION MAKING; DRUG COST; DRUG RESEARCH; EDITORIAL; HEALTH CARE SYSTEM; HUMAN; PATIENT ADVOCACY; PRIORITY JOURNAL; TEAMWORK;

COOPERATIVE BEHAVIOR; DRUG DESIGN; DRUG INDUSTRY; ECONOMIC COMPETITION; HUMANS; THERAPIES, INVESTIGATIONAL;

EID: 77951478794     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2010.39     Document Type: Editorial

References (10)

1. Paul, S.M. et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat. Rev. Drug Discov. 9, 203-214 (2010).
2. Hunter, J. & Stephens, S. Is open innovation the way forward for big pharma? Nat. Rev. Drug Discov. 9, 87-88 (2010).
3. Weber, S. The Success of Open Source (Harvard University Press, Cambridge, MA, 2004).
4. Wagner, J.A. et al. The Biomarkers Consortium: practice and pitfalls of open-source precompetitive collaboration. Clin. Pharmacol. Ther. 87, 539-542 (2010).
5. Pisano, G.P. & Verganti, R. Which kind of collaboration is right for you? Harv. Bus. Rev. (1 December 2008).
6. Altar, C.A. The Biomarkers Consortium: on the critical path of drug discovery. Clin. Pharmacol. Ther. 83, 361-364 (2008).
7. Lathia, C.D. et al. The value, qualification, and regulatory use of surrogate end points in drug development. Clin. Pharmacol. Ther. 86, 32-43 (2009).
8. Woodcock, J. Precompetitive research: a new prescription for drug development? Clin. Pharmacol. Ther. 87, 521-523 (2010).
9. Woosley, R.L., Myers, R.T. & Goodsaid, F. The Critical Path Institute's approach to precompetitive sharing and advancing regulatory science. Clin. Pharmacol. Ther. 87, 530-533 (2010).
10. Singh, M.P. Tobramycin (Cystic Fibrosis Foundation/PathoGenesis). Curr. Opin. Investig. Drugs 2, 755-765 (2001).